GEDSF
Price
$24.85
Change
+$1.15 (+4.85%)
Updated
Apr 3 closing price
Capitalization
5.62B
KKPCF
Price
$28.09
Change
+$1.18 (+4.38%)
Updated
Apr 28 closing price
Capitalization
979.79M
Interact to see
Advertisement

GEDSF vs KKPCF

Header iconGEDSF vs KKPCF Comparison
Open Charts GEDSF vs KKPCFBanner chart's image
Gedeon Richter
Price$24.85
Change+$1.15 (+4.85%)
Volume$9.5K
Capitalization5.62B
Kaken Pharmaceutical
Price$28.09
Change+$1.18 (+4.38%)
Volume$200
Capitalization979.79M
GEDSF vs KKPCF Comparison Chart in %
Loading...
GEDSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GEDSF vs. KKPCF commentary
Aug 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GEDSF is a Hold and KKPCF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 28, 2025
Stock price -- (GEDSF: $22.29 vs. KKPCF: $28.09)
Brand notoriety: GEDSF and KKPCF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: GEDSF: 100% vs. KKPCF: 100%
Market capitalization -- GEDSF: $5.62B vs. KKPCF: $979.79M
GEDSF [@Pharmaceuticals: Generic] is valued at $5.62B. KKPCF’s [@Pharmaceuticals: Generic] market capitalization is $979.79M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.86B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.8B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GEDSF’s FA Score shows that 1 FA rating(s) are green whileKKPCF’s FA Score has 1 green FA rating(s).

  • GEDSF’s FA Score: 1 green, 4 red.
  • KKPCF’s FA Score: 1 green, 4 red.
According to our system of comparison, GEDSF is a better buy in the long-term than KKPCF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GEDSF’s TA Score shows that 0 TA indicator(s) are bullish.

  • GEDSF’s TA Score: 0 bullish, 2 bearish.

Price Growth

GEDSF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while KKPCF (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +1.79%. For the same industry, the average monthly price growth was +11.19%, and the average quarterly price growth was +81.73%.

Industries' Descriptions

@Pharmaceuticals: Generic (+1.79% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GEDSF($5.62B) has a higher market cap than KKPCF($980M). KKPCF has higher P/E ratio than GEDSF: KKPCF (11.30) vs GEDSF (10.64). KKPCF YTD gains are higher at: 4.899 vs. GEDSF (-4.699). GEDSF has higher annual earnings (EBITDA): 335B vs. KKPCF (26B). GEDSF has more cash in the bank: 150B vs. KKPCF (84B). KKPCF has less debt than GEDSF: KKPCF (3.85B) vs GEDSF (21.6B). GEDSF has higher revenues than KKPCF: GEDSF (903B) vs KKPCF (87.2B).
GEDSFKKPCFGEDSF / KKPCF
Capitalization5.62B980M573%
EBITDA335B26B1,288%
Gain YTD-4.6994.899-96%
P/E Ratio10.6411.3094%
Revenue903B87.2B1,036%
Total Cash150B84B179%
Total Debt21.6B3.85B561%
FUNDAMENTALS RATINGS
GEDSF: Fundamental Ratings
GEDSF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
2
Undervalued
PROFIT vs RISK RATING
1..100
64
SMR RATING
1..100
47
PRICE GROWTH RATING
1..100
74
P/E GROWTH RATING
1..100
85
SEASONALITY SCORE
1..100
49

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GEDSFKKPCF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
N/A
N/A
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
31%
Bullish Trend 1 day ago
11%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
26%
Bullish Trend 1 day ago
11%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
49%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
GEDSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GRZZX5.07N/A
N/A
Leuthold Grizzly Short Fund
PJFCX39.56N/A
N/A
PGIM Jennison Growth C
TRREX11.42N/A
N/A
T. Rowe Price Real Estate
KTCIX52.43N/A
N/A
DWS Science and Technology Inst
SNIEX18.86N/A
N/A
BNY Mellon International Equity I

GEDSF and

Correlation & Price change

A.I.dvisor indicates that over the last year, GEDSF has been loosely correlated with APNHF. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if GEDSF jumps, then APNHF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GEDSF
1D Price
Change %
GEDSF100%
N/A
APNHF - GEDSF
51%
Loosely correlated
N/A
MSTH - GEDSF
22%
Poorly correlated
N/A
UPC - GEDSF
4%
Poorly correlated
-2.39%
KKPCF - GEDSF
3%
Poorly correlated
N/A
CLCFF - GEDSF
3%
Poorly correlated
-4.76%
More

KKPCF and

Correlation & Price change

A.I.dvisor tells us that KKPCF and OVATF have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KKPCF and OVATF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KKPCF
1D Price
Change %
KKPCF100%
N/A
OVATF - KKPCF
24%
Poorly correlated
N/A
INNPF - KKPCF
6%
Poorly correlated
+0.25%
LOVFF - KKPCF
6%
Poorly correlated
-1.74%
GEDSF - KKPCF
3%
Poorly correlated
N/A
KAYS - KKPCF
2%
Poorly correlated
-36.22%
More